skip to primary navigationskip to content

Cambridge knowledge exchange and innovation networks

last modified Apr 01, 2014 02:36 PM
Effective university-business interactions and mechanisms for the exchange of knowledge, intellectual property, technology and trained people are essential to promote innovation and economic growth.
Cambridge knowledge exchange and innovation networks

Tim Guilliams

These issues were discussed at a debate entitled From Lab to Market?, organised by the Cambridge University Science and Policy Exchange (CUSPE) and supported by ideaSpace, Healx3, a company based at ideaSpace West, the Centre for Science and Policy (CSaP), Cambridge Innovation Forum and MedImmune.

Tim Guilliams, founder and CEO at Healx3, wrote a blog post on the proceedings entitled Cambridge knowledge exchange and innovation networks and it featured prominently on the National Centre for Universities & Business (NCUB) website – it was on the front page.

In the blog post, Tim says that understanding how university-business interactions and mechanisms can be improved to maximise academic impact on the economy is a subject that is high on the UK Government agenda.

He says: “There is no doubt that the transfer of technology and intellectual property between universities and businesses is important. However, one could argue that facilitating effective networks and knowledge exchange between both sectors might even have a greater impact on the country’s development.”

Tim is Director of Knowledge Exchange at Cambridge Innovation Forum, co-founder of CUSPE and a Junior Associate Fellow of CSaP.

To read Tim’s blog post in full visit here.

RSS Feed Latest news

Polysolar celebrate Top Innovation Award

Oct 10, 2016

Polysolar who develop, design, and project-manage Building Integrated Photovoltaic (BIPV) solutions have won Cambridge News Top Innovation 2016 Award

Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases

Oct 05, 2016

Amadeus Capital Partners, the global technology investor, has made an early-stage investment of £1.5 million in ideaSpace alumni Healx, a Cambridge based healthcare company that seeks new uses for existing drugs in the fight against rare diseases.

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

Sep 29, 2016

The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.

GeneAdviser raises £350K to boost uptake of genomic medicine

Jun 02, 2016

GeneAdviser, an online ordering platform for clinical genetic testing, has raised £350,000 in its first round of seed funding, backed by Cambridge biotech angel Dr Jonathan Milner.

View all news